Skip to main content
SpringerLink
Log in

Thalidomide: Review of the 10 Year Intensive Pharmacovigilance Program in Argentina

  • Abstracts
  • Published:
Drug Safety Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bignone IM, Papale RM, Seoane MR, et al. Thalidomide. New trends for therapeutic use. Controlled distribution system. Naunyn-Schmideberg Arch. Pharmaol 1998; 358 (Suppl 2): R479

    Google Scholar 

  2. Katzel JA, Hari P, Vesole D. Multiple Myeloma Charging Toward a Bright Future. CA Cancer J Clin 2007; 57:301–18

    Article  PubMed  Google Scholar 

  3. Clark TE, Edom N, Larson J, et al. Thalidomid® (Thalidomide) Capsules: A review of th first 18 months of Spontaneous postmarketing adverse event surveillance, including off-label prescribing. Drug Safety 2001; 24(2): 87–117

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Administración Nacional de Medicamentos, Alimentos y Tecnologia Mfédica, Argentina

    C. Santucci, R. Papale, A. Perez, B. Cardoso & I. Bignone

Authors
  1. C. Santucci
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Papale
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Perez
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B. Cardoso
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. I. Bignone
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Santucci, C., Papale, R., Perez, A. et al. Thalidomide: Review of the 10 Year Intensive Pharmacovigilance Program in Argentina. Drug-Safety 31, 885 (2008). https://doi.org/10.2165/00002018-200831100-00168

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-200831100-00168

Keywords

Search

Navigation